Key result
Transcatheter ASD closure in children under 10 kg achieves ~99% procedural success and halves severe malnutrition.
Why the study?
Surgical treatment rather than transcatheter closure is recommended for young patients with small bodyweight presenting early with an oval fossa defect, heart failure, and pulmonary hypertension.
Does transcatheter device closure of atrial septal defects safely improve symptoms and growth in symptomatic children weighing less than 10 kg compared to children weighing more than 10 kg?
Cohort (n=256)
Does transcatheter device closure of atrial septal defects safely improve symptoms and growth in symptomatic children weighing less than 10 kg compared to children weighing more than 10 kg?
Transcatheter ASD closure under conscious sedation and transthoracic echocardiography guidance is safe and effective in symptomatic children weighing under 10 kg, challenging recommendations that favor surgical closure in this low-weight group.
Answers are grounded in this paper and cite their sources.
May support transcatheter ASD closure in symptomatic infants <10 kg; leaves open randomized trials versus surgery.
BACKGROUND: When young patients with an oval fossa defect present early with symptoms of heart failure and pulmonary hypertension, surgical treatment is recommended in small bodyweight rather than transcatheter closure. METHODS: Outcomes of device closure in consecutive symptomatic children weighing under 10 kg were compared with young children aged below 4 years but weighing above 10 kg. Transthoracic echocardiography under conscious sedation guided the procedure in all without need for balloon sizing, transesophageal echocardiogram, and intubation anaesthesia. Symptoms, anthropometry, shunt ratio, pulmonary pressures, defect and device size, percentage oversizing, device/body weight ratio, complications, and post-procedural growth spurt were compared. RESULTS: Ninety-six patients weighing under 10 kg were compared with 160 patients weighing above 10 kg. In total, 83.3% of patients in the study group and 25% of controls were severely malnourished. The median indexed defect size was 35.2 mm/sq.m and 27.4 mm/sq.m, and the device was oversized by 8.7% and 14.2% in the study group and controls, respectively. The device/body weight ratio was 1.93 in study group and 1.4 in controls. Procedure was successful in all except one patient weighing under 10 kg who had a device embolisation. Both groups showed significant growth spurts and proportion, with severe malnutrition reduced to 42% and 11% in the two groups. CONCLUSIONS: Device closure was feasible and safe in patients under 10 kg. Transthoracic echocardiographic imaging on conscious sedation provided adequate guidance. Symptoms and growth significantly improved after intervention. Despite a larger defect size, smaller patients had comparable outcomes. In symptomatic children under 10 kg needing early closure, transcatheter intervention should not be deferred.
No takes yet. Share an insight, caveat, or question.
Thejaswi et al. (2024) conducted a cohort in Oval fossa atrial septal defect with symptoms of heart failure and pulmonary hypertension (n=256). Transcatheter device closure of atrial septal defect in children weighing <10 kg vs. Transcatheter device closure of atrial septal defect in children aged <4 years weighing >10 kg was evaluated on Procedural success and post-procedural reduction in severe malnutrition. Transcatheter ASD closure in children <10 kg was successful in 99% (95/96 vs 160/160 in >10 kg) and reduced severe malnutrition from 83.3% to 42%.
Synapse has enriched 10 related papers. Consider them for comparative context: